Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE, RP1 Clinical Trial Not Allowed)
Grant Opportunity Analysis
The National Institutes of Health (NIH) is offering a grant opportunity titled "Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE, RP1 Clinical Trial Not Allowed)" aimed at advancing research in cancer biology and radiopharmaceutical therapy. This initiative seeks to support projects that utilize innovative cancer biology approaches and preclinical models to explore the biological effects of radiation from radionuclides, with the goal of improving therapeutic outcomes in cancer treatment. The STRIPE program is designed to foster multidisciplinary research, generating insights that could lead to new targeting strategies and optimized treatment regimens for radiopharmaceutical therapies. Interested applicants can submit proposals for either exploratory/developmental projects (up to 2 years) or research projects (4 to 5 years), with no cost-sharing requirements. For further information, applicants can contact the STRIPE-Program NCI at STRIPE-ProgramContact@mail.nih.gov or by phone at 240-276-5690. The estimated synopsis close date is October 5, 2026, with awards expected to be made by July 1, 2027.
Eligible Applicants
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
Grant Documents
No documents available for this grant.